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Abstract
One of the earliest morphogenetic processes in the development of many animals is epiboly. In the zebrafish, epiboly
ensues when the animally localized blastoderm cells spread, thin over, and enclose the vegetally localized yolk. Only a few
factors are known to function in this fundamental process. We identified a maternal-effect mutant, betty boop (bbp), which
displays a novel defect in epiboly, wherein the blastoderm margin constricts dramatically, precisely when half of the yolk
cell is covered by the blastoderm, causing the yolk cell to burst. Whole-blastoderm transplants and mRNA microinjection
rescue demonstrate that Bbp functions in the yolk cell to regulate epiboly. We positionally cloned the maternal-effect bbp
mutant gene and identified it as the zebrafish homolog of the serine-threonine kinase Mitogen Activated Protein Kinase
Activated Protein Kinase 2, or MAPKAPK2, which was not previously known to function in embryonic development. We
show that the regulation of MAPKAPK2 is conserved and p38 MAP kinase functions upstream of MAPKAPK2 in regulating
epiboly in the zebrafish embryo. Dramatic alterations in calcium dynamics, together with the massive marginal constrictive
force observed in bbp mutants, indicate precocious constriction of an F-actin network within the yolk cell, which first forms
at 50% epiboly and regulates epiboly progression. We show that MAPKAPK2 activity and its regulator p38 MAPK function in
the yolk cell to regulate the process of epiboly, identifying a new pathway regulating this cell movement process. We
postulate that a p38 MAPKAPK2 kinase cascade modulates the activity of F-actin at the yolk cell margin circumference
allowing the gradual closure of the blastopore as epiboly progresses.
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Introduction
Early embryonic development is marked by cellular movements
that ultimately generate the shape of the embryo in a process
known as morphogenesis. One of the earliest morphogenetic
events in many animals is the process of epiboly, whereby
embryonic tissues spread and thin [1–5]. In the zebrafish embryo,
three distinct cell layers lying at the animal pole of the embryo
undergo epiboly: the enveloping layer (EVL) and yolk syncytial
layer (YSL), both of which are extraembryonic, and an
intermediate deep cell layer that forms the embryo proper
(Fig. 1). About 1 hour after the mid-blastula transition, the
morphogenetic process of epiboly begins. The deep blastomeres
radially intercalate, while the underlying yolk moves animalward
in a process called doming. At completion of this initial phase of
epiboly, an inverted bowl-shaped blastoderm covers ,50% of the
yolk surface, referred to as the 50% epiboly stage (Fig. 1). During
the second phase of epiboly, the deep cells begin gastrulation cell
movements converging dorsally and undergoing involution/
ingression movements to form the germ layers [5]. At the same
time, epiboly continues with all three cell layers spreading over the
yolk to the vegetal pole of the embryo, ultimately resulting in the
complete internalization of the yolk [6]. The morphogenetic
process of epiboly also occurs in numerous other vertebrates and
invertebrates, including amphibia, sea urchins, and C.elegans [1–
4].
The YSL actively participates in epiboly. Within the YSL,
microtubule organizing centers associated with the yolk syncytial
nuclei (YSN) extend microtubule arrays vegetally into the cortical
yolk cytoplasmic layer (YCL) (Fig. 1). Ablation of microtubules
with UV treatment or nocodazole slows or arrests epiboly
progression [7,8]. Studies of YSN movements suggest that
movement of blastomeres and YSN are coordinated [9]. Although
the mechanism remains unknown, E-cadherin is required for the
coupling of the deep cells to the YSL and EVL in coordinating this
movement between tissue layers in zebrafish [10–12]. In Xenopus
fibronectin-integrin cell adhesion interactions act in radial
intercalation during epiboly [13]. As the EVL and blastoderm
cells move over the yolk, the yolk cell membrane is actively
removed via endocytosis [14]. Also within the YSL is an actin
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epiboly movements and is postulated to close the blastopore (the
uncovered vegetal yolk surface) as epiboly progresses (Fig. 1) [15–
17].
Although epiboly is a fundamental morphogenetic process, only
a handful of factors have been identified regulating this process.
To identify additional molecular regulators, we investigated the
zebrafish maternal-effect mutant, betty boop (bbp), which displays a
novel defect in epiboly [18,19]. In bbp mutants the leading edge of
the blastoderm constricts dramatically at 50% epiboly causing the
yolk cell to burst. This defect in epiboly is not seen in other
mutants or by pharmacological treatments, suggesting that a novel
aspect of epiboly is affected. Through whole blastoderm
transplants and mRNA microinjection rescue, we determined
that Bbp functions in the yolk cell. Consistent with it having a
novel function in epiboly, we found that microtubules, actin band
formation and endocytosis in the YSL appear normal prior to the
onset of the phenotype. We positionally cloned the bbp mutant
gene and identified it as the zebrafish homolog of Mitogen
Activated Protein Kinase Activated Protein Kinase 2 (MAP-
KAPK2). Mutation of the p38 MAP kinase phosphorylation sites
in MAPKAPK2 implicates p38 in regulating MAPKAPK2
function. Expression of a dominant-negative p38 MAP kinase
demonstrates that it functions in a similar manner to MAPKAPK2
in epiboly. Furthermore, we found a dramatic increase in calcium
release in bbp mutants, possibly reflecting altered actin contraction.
Thus, we identified the p38 MAPAPK2 pathway as a new
regulator of the fundamental morphogenetic process of epiboly.
We propose that the p38 MAPKAPK2 kinase cascade modulates
actin contraction at the blastoderm margin to close the blastopore
during normal epiboly progression.
Results
bbp Mutants Display Precocious Blastopore Constriction
In a maternal-effect screen, we identified a mutant, bbp, which
displays a striking morphogenesis defect in epiboly [18]. bbp
mutant embryos appear to develop normally until 50% epiboly
(Fig. 2 A,B); however, just as the blastoderm cells reach 50%
epiboly, the equator constricts around its circumference, causing
the yolk cell to burst (Fig. 2 B0). This defect is a 100% penetrant,
maternal-effect phenotype, in which all embryos from homozy-
gous females are mutant (hereafter called bbp mutant embryos),
irrespective of their paternal genotype. Time-lapse microscopy of
mutant (n=9) and wild-type (WT) (n=9) embryos (Fig. 2 C–D)
shows that bbp embryos undergo abnormal shimmying movements
periodically during blastula stages. That is, rapid, abnormal
movements of large regions of the blastoderm, which increase in
amplitude until the constriction and bursting of the yolk (Video
S1).
We investigated if defects in patterning could account for the bbp
phenotype. We found that the expression of goosecoid (Fig. 3 A, D),
a dorsal organizer marker, and no tail (Fig. 3 B, E), a mesodermal
marker, was normal in bbp embryos (n=10, 13 respectively).
Analysis of bmp4 and eve1 expression in ventral and ventrolateral
regions, as well as foxb1.2 [20] in dorsal regions confirmed that
patterning is normal in bbp embryos (data not shown). Thus, the
defect in bbp appears to be specific to the morphogenetic process of
epiboly.
Proper epiboly progression depends on microtubules that are
present in the yolk cell [7,8]. We analyzed microtubule array
formation in the YCL (yolk cytoplasmic layer) at 50% epiboly just
prior to bursting. Anti-tubulin stainings showed that microtubules
are properly formed and robust in mutant embryos (Fig. 3 F,
n=23), similar to WT embryos (Fig. 3 C, n=17). Thus,
microtubule array formation does not appear defective in bbp
embryos.
As epiboly progresses, the yolk cell membrane adjacent to the
advancing blastoderm cells is removed via endocytosis. This
process decreases the yolk cell membrane during epiboly, as the
deep cells, EVL and YSN move over the yolk cell, and may drive
their vegetal movement [14,16]. We found that bbp mutant (n=8)
and WT (n=10) embryos both internalized Rhodamine-dextran
dye (Fig. 3 G,H), indicating that endocytosis was normal and is
unlikely the cause of the epiboly defect.
It was unclear if the primary cause of the bursting of bbp
embryos is the marginal constriction or a loss of yolk membrane
integrity, which secondarily leads to the buckling of the blastoderm
margin. To distinguish between these possibilities, we incubated
WT and bbp embryos in hypertonic media to stabilize the yolk
membrane in an attempt to prevent it from failing during the
manifestation of the phenotype. The hypertonic medium caused
no defects in WT embryos (Fig. 3 N) and stabilized the yolk
membrane of bbp mutants, as evident by the lack of yolk globules
protruding through the membrane (Fig. 3 K, L arrowheads).
Importantly, despite the stabilized membrane, bbp embryos
continued to constrict around their circumference at 50% epiboly
in the hypertonic medium without causing the yolk to burst (Fig. 3
L, n=56). Eventually the blastoderm pinched off from the vegetal
yolk and healed, and the embryo continued to develop to 1 day
post fertilization (dpf) (Fig. 3 M). This result indicates that the
bursting phenotype results from a mechanical constriction, rather
than from a yolk membrane integrity defect.
It is thought that a slow and controlled constriction of an actin
ring present in the YSL closes the blastopore as epiboly progresses
in the Fundulus embryo [15]. Similarly, in zebrafish a punctate
actin band forms just vegetal to the blastoderm/EVL margin in
the yolk cell at the 50% epiboly stage [16]. This actin band
coincides with the region of yolk cell membrane endocytosis [16]
and the marginal constriction of EVL cells during epiboly [21].
Phalloidin staining shows that an F-actin band forms in the YSL
and at the EVL margin of bbp embryos (Fig. 3 J, n=15), as in WT
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actin functions normally during epiboly.
We investigated the timing of the marginal constriction in bbp
mutant embryos to distinguish between two alternative defects.
One possibility is that the vegetal-ward movement of the
blastoderm is arrested in bbp embryos, while blastopore closure
is unaffected, thus causing the observed marginal constriction as
the blastopore gradually tries to close in the absence of vegetal-
ward cell movement. Such a constriction defect is seen in a subset
of embryos in which microtubule function is blocked [7,8] and in
embryos depleted of Mtx2, a presumptive transcription factor
acting in the yolk cell to regulate epiboly [22,23]. Alternatively, the
marginal constriction could arise due to too rapid closing of the
blastopore, i.e. precocious blastopore closure, caused by unregu-
lated actin constriction. We found that the margin does not
constrict gradually over a ,3 hour period as in WT, but instead
occurs rapidly within a 20 to 30 minute period in bbp mutants
(Fig. 2 and Video S1). This result is consistent with a model in
which the blastopore closes precociously in bbp mutants through
an unregulated marginal F-actin constriction.
We examined the behavior of the yolk syncytial nuclei (YSN) in
bbp mutant embryos to determine if YSL morphogenesis is
affected. Below the blastoderm at 50% epiboly, the internal YSN
(I-YSN) are widely distributed, while at the margin the external
YSN (E-YSN) are more densely packed [7–9]. In time-lapse
analysis of fluorescently labeled nuclei, we observed a normal
distribution of the I-YSN during epiboly in bbp mutant and WT
embryos. However, following a strong shimmying movement and
coincident with the onset of the marginal constriction shortly
before bbp mutants burst, the I-YSN withdrew from the location of
a strong shimmying movement and collapsed into a small area of
the I-YSL (Fig. 3 O–V, Video S2, S3). The E-YSN remained in
place until the yolk cell burst minutes later. Thus, YSN epiboly
movements appeared normal in bbp mutants until 50% epiboly,
when strong shimmying movements and the marginal constriction
likely cause them to behave abnormally secondarily.
bbp Mutants Display Aberrant Calcium Dynamics
During early epiboly stages, calcium levels are low throughout
the embryo; however, beginning at 50% epiboly calcium levels
become dynamic and are required for formation of the yolk cell
actin band and epiboly progression [16,24–26]. We investigated if
calcium dynamics are altered in bbp mutants during epiboly, which
could reflect a change in the yolk cell F-actin function. We
examined calcium dynamics by ratiometric imaging with the
fluorescent calcium indicator, Fura-2. Time-lapse microscopy and
transient composite analysis of calcium activity showed a dramatic
increase in calcium release in bbp mutants (n=7) compared to WT
embryos (Video S4 and S5). During early epiboly when doming of
the yolk occurs, calcium activity is maintained at a sustained level
Figure 1. Schematic of epiboly progression. Epiboly begins when the yolk (yellow) domes toward the animal pole (top), concomitant with radial
intercalation of the deep cells of the blastoderm (green) to cover 30% of the embryo surface. At 30% epiboly, the yolk syncytial nuclei (YSN, dark-
green circles) are maintained within the yolk syncytial layer (YSL) beneath the blastoderm and are associated with microtubules (black lines, surface
view) that are oriented toward the vegetal pole within the very thin cortical, yolk cytoplasmic layer (YCL, light blue in cross-section). The enveloping
layer (EVL, pink) forms a thin epithelial-like sheath on the surface of the deep cells and is connected to the YSL at the cell margin. The YCL cannot be
distinguished from the yolk when viewed from the lateral surface. At 50% epiboly, the EVL and deep cells cover 50% of the embryo and lie more
vegetally than the YSN, masking the YSN in the lateral surface view. An actin band (turquoise) forms in the YSL just vegetal to the margin at 50%
epiboly and likely functions as a contractile mechanism to close the blastopore throughout the remainder of the epiboly process. By 75% epiboly, the
YSN are located beneath the blastoderm, as well as vegetal to it (surface view). The blastopore is the exposed vegetal yolk, which continually
decreases in circumference as epiboly progresses.
doi:10.1371/journal.pgen.1000413.g001
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embryos, ectopic calcium release activity was observed (Fig. 4 B,
arrowheads). This ectopic release increased in frequency and
intensity as epiboly progressed (Fig. 4 C, arrowheads) until
eventual bursting. Analysis of calcium flux throughout early
epiboly in a composite pseudo-colored image shows low calcium
activity at the margin in WT (Fig. 4 D), which is clearly increased
in bbp embryos (Fig. 4 E, F). Thus the increased calcium release
may lead to increased contraction of F-actin at the yolk margin
and the dramatic constriction observed in bbp mutant embryos.
The YSL Is the Critical Domain of Bbp Function
The Bbp protein may function in the yolk cell, deep cells or
EVL. To determine the embryonic domain in which Bbp
functions, we performed whole blastoderm transplants to separate
yolk, YSL, and YCL structures from the deep cells of the
blastoderm and EVL [27]. WT blastoderms were then placed on
bbp yolks, and vice versa (Fig. 5 A). Chimeric embryos containing
WT yolk and mutant blastoderm completed epiboly (Fig. 5 B–B90,
n=5) and were viable through at least 6 dpf (data not shown). In
contrast, chimeric embryos containing mutant yolk and WT
blastoderm constricted at the equator and burst at 50% epiboly
(Fig. 5 C–C0, n=7), similar to bbp embryos. These data indicate
that Bbp functions in the yolk cell to regulate epiboly, consistent
with it modulating the closing of the blastopore via actin
constriction within the yolk cell.
bbp Encodes MAPKAPK2
To identify the molecular nature of bbp, we mapped the bbp
mutation to the centromere of chromosome 11 using SSLP (simple
sequence length polymorphic) markers [28] in bulk segregational
analysis of homozygous mutant versus WT sibling adult female
fish. The interval was narrowed by fine recombination mapping
using more than 1100 meiotic events to a 900 kb interval based on
the Sanger Centre zebrafish genome sequence (www.ensembl.org/
Danio_rerio). Ten novel ESTs and one known cDNA were
present in the critical interval. RT-PCR of ovary cDNA identified
7 ESTs and the one known cDNA as maternally-supplied RNAs
(data not shown). Systematic sequencing of these genes from WT
and bbp mutant ovary cDNA identified a non-sense mutation
(Fig. 6A) in the known serine-threonine kinase gene, Mitogen
Activated Protein Kinase Activated Protein Kinase 2 (MAP-
KAPK2). Sequence analysis of the genomic region of the parental
mutagenized fish demonstrated that this mutation did not exist in
the background and thus was induced by the ENU mutagenesis.
The mutation introduces a premature stop codon, predicting a
carboxy-terminal 33 amino acid truncation, which removes an
identified nuclear localization signal and a p38 docking domain
(Fig. 6A) [29,30]. The MAPKAPK2 transcript is present
maternally in the egg and is found ubiquitously in the blastoderm
through the 50% epiboly stage (data not shown, Fig. 6C,D).
The bbp phenotype could be rescued by injection of 20 pg of
WT MAPKAPK2 mRNA at the 1-cell stage (n.500, 100%
rescue), demonstrating that MAPKAPK2 is the gene defective in
bbp mutants. This is among the first maternal-effect mutant genes
to be cloned positionally in a vertebrate. Importantly, injection of
WT MAPKAPK2 mRNA into the YSL at the 512- to 1000-cell
stage rescued the constriction defect and the calcium defect of bbp
mutant embryos, confirming that MAPKAPK2 is required in the
yolk cell (n=20, 100% rescued). Injection of 1.5 ng of mutant
MAPKAPK2 mRNA (75-fold overexpression compared to WT
mRNA) had no rescuing activity (n=75). Furthermore, injection
of mutant MAPKAPK2 mRNA (250 pg to 1.25 ng, n.50) into
WT embryos caused no phenotypic consequences, indicating that
the mutant protein is inactive and has no dominant-inhibitory
activity when overexpressed. In conjunction with rescuing
amounts of MAPKAPK2 mRNA, we injected a translation
blocking morpholino to MAPKAPK2 into bbp mutant embryos.
Rescue was inhibited by the morpholino (n=17, 100% no rescue;
100% rescued by mRNA injection alone), suggesting that it can
block translation. However, morpholino injection alone into WT
embryos did not phenocopy bbp (n=14), possibly due to
maternally-supplied MAPKAPK2 protein or high maternal levels
of transcript.
MAPKAPK2 is a well-characterized direct target of p38 MAP
kinase (MAPK). p38 MAPK activates MAPKAPK2 by phosphor-
ylating key residues on MAPKAPK2. MAPKAPK2 has been
extensively studied in cell culture, including structure function
analysis, and the identification of nuclear and cytoplasmic targets
[31]. However, very few of the results from these cell culture
studies have been tested in an animal model.
Subcellular Localization of Bbp Mutant MAPKAPK2
Studies of mammalian MAPKAPK2 in cell culture show that
the protein is localized to the nucleus under basal conditions, but
upon phosphorylation by p38 MAPK, an overriding nuclear
export signal (NES) stimulates its export to the cytoplasm
[29,30,32,33]. The carboxy-terminal truncation of MAPKAPK2
in bbp mutants results in loss of the NLS (Fig. 6A), suggesting that
the mutant protein may be constitutively localized to the
cytoplasm and fail to phosphorylate nuclear targets, thus causing
its loss of function. To address this question, we examined the
subcellular localization of myc-tagged WT and Bbp MAPKAPK2
proteins in embryos. The myc-fusion did not compromise
MAPKAPK2 activity, as it fully rescued the bbp mutant phenotype
(Fig. 6E, n=108, 100% rescued). We found that WT myc-
MAPKAPK2 predominantly localized to the nucleus, with
additional weak localization in the cytoplasm, consistent with
previous studies in mammalian cells (Fig. 6F, n=12). Bbp myc-
MAPKAPK2 showed increased localization to the cytoplasm and
the cell cortex. Surprisingly, a significant amount of the mutant
fusion protein remained in the nucleus, despite loss of the NLS
(Fig. 6G, n=10). GFP-fusions to WT and the Bbp mutant proteins
behaved similarly, except that the WT GFP-fusion was found
exclusively in the nucleus (data not shown). The inability of the
mutant fusion proteins to rescue the mutant phenotype (myc-Bbp,
n=14; GFP-Bbp, n=14) despite their nuclear localization,
indicates that other properties of MAPKAPK2 are deficient in
the Bbp protein. These results also suggest that interacting factors
or additional features of MAPKAPK2 can localize it to the nucleus
in the absence of the NLS.
Bbp MAPKAPK2 Lacks Kinase Activity
We next investigated the kinase activity of the mutant protein to
determine if it was constitutively active in the cytoplasm or
otherwise misregulated. We analyzed the phosphorylation status of
a well-established cytoplasmic substrate of MAPKAPK2, heat
shock protein 27 (HSP27) [31]. Antibodies specific to the
Figure 2. bbp embryos constrict at the margin at 50% epiboly, bursting the yolk. Still images of WT and bbp embryos at the 1000-cell stage
(A, B), 50% epiboly (A9,B 9), and 50% epiboly at the burst (A0,B 0). bbp embryos constrict just as they reach 50% epiboly. (C and D) Selected frames
from time-lapse movies of WT and bbp embryos showing that the constriction occurs rapidly once the embryos have reached 50% epiboly.
doi:10.1371/journal.pgen.1000413.g002
MAPKAPK2 in Development
PLoS Genetics | www.plosgenetics.org 5 March 2009 | Volume 5 | Issue 3 | e1000413MAPKAPK2 in Development
PLoS Genetics | www.plosgenetics.org 6 March 2009 | Volume 5 | Issue 3 | e1000413phosphorylated form of HSP27 did not detect the endogenous
zebrafish protein in embryos. Therefore, we analyzed the activity
of WT and Bbp MAPKAPK2 in transfected HeLa cells. We first
confirmed that the subcellular localization of the proteins in HeLa
cells recapitulated that seen in intact embryos (data not shown).
We next examined their ability to induce phosphorylation of
HSP27. As shown in Fig. 6J (top panel), the Bbp protein was
expressed at levels comparable to the WT protein, suggesting that
the stability of the mutant protein is not grossly affected.
Expression of WT MAPKAPK2 induced robust phosphorylation
of endogenous HSP27 (Fig. 6J, bottom panel). Unexpectedly, Bbp
was significantly impaired in its ability to induce phosphorylation
of HSP27, despite the fact that its kinase domain is intact, as well
as the three predicted MAPK phosphorylation sites (Fig. 6A, J).
These results indicate that the Bbp mutant protein is defective in
its kinase activity, causing its loss-of-function phenotype.
To test directly if MAPKAPK2 kinase activity is required for it
to regulate epiboly, we generated a myc-tagged full-length kinase
dead protein by changing the critical lysine in the catalytic domain
to a methionine (K73M) [34], and assayed activity in both cell
culture and zebrafish embryos. As expected, kinase-dead MAP-
KAPK2 failed to induce phosphorylation of HSP27 in a HeLa cell
culture assay (Fig. 6I, bottom panel). In bbp mutant embryos,
injection of 200 pg of the kinase dead MAPKAPK2, although
stably expressed in the embryo (Fig. 6K), failed to rescue the
mutant phenotype (n=99, Fig. 6B), in contrast to the WT protein
(Fig. 6E). These results demonstrate that the kinase activity of
MAPKAPK2 is required for its function in epiboly, indicating that
the Bbp mutant protein fails to phosphorylate a critical target in
the yolk cell that regulates epiboly.
p38 MAPK Required for MAPKAPK2 Function
The carboxy-terminal region truncated in Bbp also contains a
p38 docking site, which is important for p38 to phosphorylate
MAPKAPK2 efficiently [35,36]. The lack of kinase activity of the
Bbp mutant protein may be due to failure of p38 to efficiently
phosphorylate and thus activate the Bbp protein. To investigate if
p38 regulates MAPKAPK2 activity, we mutated the three p38
phosphorylation sites of MAPKAPK2 [29,30,37–39]. Based on the
mammalian MAPKAPK2 structure, zebrafish MAPKAPK2 is
expected to be phosphorylated on Threonine 202, Serine 252, and
Threonine 315 by p38 MAPK (Fig. 6A). We mutated these three
residues of zebrafish MAPKAPK2 to Alanines, any two of which
when mutated in cell culture cause a failure in MAPKAPK2
activation [37]. In contrast to these cell culture studies, we found
that the T202A/T315A double mutant MAPKAPK2 rescued bbp
mutant embryos (40 pg, 15/16 rescued; 90 pg, 47/47 rescued).
However, injection of 150 pg of the triple phospho-mutant RNA,
although stably expressed (Fig. 6H, K), failed to rescue the mutant
phenotype (n=70), indicating the importance of these three sites
in MAPKAPK2 function in epiboly. We also investigated the
activity of the MAPKAPK2 phosphorylation site mutants in our
Figure 3. Characterization of bbp phenotype. In situ hybridization of goosecoid (gsc) in WT (A) and bbp (D) and no tail (ntl) in WT (B) and bbp (E)
embryos at 50% epiboly. Microtubule array forms normally in bbp embryo (F) at the approach to 50% epiboly as in WT (C). G, H Internalization of
Rhodamine-dextran through endocytosis in the YSL at 50% epiboly in WT (G) and a bbp (H) embryo. Rhodamine-Phalloidin staining in WT (I) and bbp
(J) embryos at 50% epiboly. White brackets show punctate actin band in YSL, arrowheads indicate actin at EVL margin. Hypertonic Ringer’s solution
extended development of constricting bbp embryos. bbp embryo ni E3 medium constricts at 50% epiboly and yolk globules (black arrowheads) burst
through the yolk membrane (K). bbp embryo reared in hypertonic medium constricts, while maintaining yolk membrane integrity (L), allowing the
blastoderm to heal and survive to 24 hpf (M). Mutants can undergo gastrulation movements and generate a general body plan at 24 hpf. WT sibling
reared in hypertonic medium develops normally, shown at 50% epiboly (N). YSN of WT embryo labeled with Sytox Green (O–R); both I-YSN (bracket)
and E-YSN (arrowhead) change little during this short time interval. (S–V) bbp I-YSN are initially distributed normally under the blastoderm, but retract
rapidly to a small region of the I-YSL (arrow) when the margin constricts, just before yolk cell rupture.
doi:10.1371/journal.pgen.1000413.g003
Figure 4. Ectopic calcium release. Selected frames of ratiometric images of WT (A) and bbp at early epiboly (B) and bbp at 40% epiboly (C).
Algorithm of the calcium release representing the frequency and location of fluxes for the duration of the time course of early WT embryo in A (D),
early bbp embryo in B (E), and 40% epiboly bbp embryo in C (F). Composites represent data collected over 1 hour of imaging of an individual embryo.
doi:10.1371/journal.pgen.1000413.g004
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rescue data (Fig. 6I).
Thus, our results show that Ser252 is sufficient in the zebrafish
embryo and HeLa cells for MAPKAPK2 protein function,
contrasting previous studies in other cell culture systems. Consid-
ering that the three p38 phospho-residues are conserved in all
MAPKAPK2 genes, we postulate that one or more of these residues
is required to activate MAPKAPK2 depending on the cellular
context. Taken together, we postulate that the lack of kinase activity
of the truncated Bbp MAPKAPK2 is due to a loss of the p38
docking site in the Bbp mutant protein, resulting in an inability of
p38 to bind, phosphorylate, and thus activate the mutant protein.
To test directly if p38 MAPK could be the upstream activator of
MAPKAPK2, we investigated p38 function in epiboly progression
Figure 5. Whole blastoderm transplants show yolk cell domain of function. Embryos were injected with rhodamine-dextran (bbp) or sytox
green dye (WT) at the 1-cell stage. Blastoderms were separated from yolks and re-adhered creating chimeric embryos. (A) Schematic representation
of the blastoderm transplant. A chimeric embryo (B–B90) containing a WT yolk (B9) and bbp blastoderm (B0) progresses through epiboly properly (B90,
80% epiboly). A chimeric embryo (C–C0) containing a WT blastoderm (C9) and bbp yolk (C0) constricts at 50% epiboly, showing that Bbp functions in
the yolk cell during epiboly. Bright field images of chimeric embryos, B, C. WT derived tissue, B9,C 9. bbp derived tissue, B0,C 0. Merge of images at 80%
epiboly in B90.
doi:10.1371/journal.pgen.1000413.g005
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PLoS Genetics | www.plosgenetics.org 8 March 2009 | Volume 5 | Issue 3 | e1000413Figure 6. Zebrafish MAPKAPK2 protein schematic, sub-cellular localization, and kinase activity. (A) Top panel: Full length protein of 382
amino acids, with catalytic domain (red) adjacent to the carboxy-terminal regulatory domains (blue, purple). Residues T202, S252, and T315 (*) are
phosphorylated by p38 MAPK. K73M is the kinase dead mutation generated. The Q350 residue (black arrowhead) is mutated to a premature stop
codon in bbp, thus creating a truncated protein lacking the most carboxy-terminal regulatory domains (purple). Bottom panel: Scale representation of
carboxy-terminal regulatory domains, including the auto-inhibitory helix that slightly overlaps an NES, and the NLS that also contains residues
required for p38 MAPK docking (p38). (B) bbp embryo injected with kinase-dead full-length myc-tagged MAPKAPK2 (MK2), which does not rescue;
shown at 50% epiboly when the constriction initiated. (C,D) Wholemount in situ hybridization of MK2 (bbp) antisense and control sense probes at
50% epiboly in WT embryos. (E) bbp embryo injected with full-length myc-tagged MK2 mRNA at the 1-cell stage is rescued; shown at 75% epiboly. (F–
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p38a is expressed maternally and throughout blastoderm stages in
the zebrafish [40,41]. Microinjection of 250 pg of DNp38a
mRNA caused 60% of the embryos to display a phenotype
similar or identical to that of bbp mutant embryos (Fig. 7A,B,
n=155). In time-lapse microscopy analysis shimmying movements
were observed in DNp38-injected embryos, similar to those seen in
bbp mutants. Likewise, at or slightly after 50% epiboly, the
blastoderm margin constricted strongly, followed by the yolk cell
bursting (Video S6). These results support a role for p38 MAPK in
regulating the activity of MAPKAPK2 in epiboly in the zebrafish.
Discussion
The coordination of cell movements during developmental
processes such as epiboly is not well understood. Although a
fundamental cell movement process, few molecular components
regulating epiboly have been described. Those that have been
described are isolated components, not yet integrated into gene
pathways. Here we identified a novel function for MAPKAPK2
and p38 MAPK in modulating this morphogenetic process in the
early zebrafish embryo. MAPKAPK2 is required to prevent the
premature constriction of the blastopore observed in bbp mutants.
p38 MAPK is also required in this process, since mutating the
three p38 MAPK phosphorylation sites in MAPKAPK2 abrogates
its function and a dominant negative p38 MAPK phenocopies the
bbp mutant phenotype. These results indicate that p38 MAPK
regulates MAPKAPK2 activity during epiboly in zebrafish
through the well-known MAP kinase cascade pathway.
Loss of MAPKAPK2 or p38 MAPK function causes premature
constriction of the blastoderm margin, which ruptures the yolk cell
and causes lethality. We can block yolk cell rupture by incubation
in hypertonic media (Fig. 3 L); however, the marginal constriction
persists in these conditions, indicating that the rupture and
constriction are not simply due to a defect in yolk cell membrane
integrity. We show that MAPKAPK2 functions within the yolk cell
and postulate that it modulates actin-based contractility to close
the blastopore during epiboly. The blastopore is at its greatest
circumference at 50% epiboly (Fig. 1). Following that stage, the
blastoderm cells migrate uniformly vegetally causing the blasto-
pore circumference to continuously decrease in a purse-string like
fashion until the blastopore is completely closed at 100% epiboly.
Electron microscopy studies in Fundulus reveal an actin ring in the
YSL adjacent to the blastoderm margin that is postulated to act as
the strings during blastopore closure [15]. In zebrafish an F-actin
band is first evident at 50% epiboly in a similar location in the
YSL [16]. This actin band is associated with an active form of
myosin, phosphorylated-myosin 2 [17], indicating the presence of
an actin-myosin contractile activity in the YSL margin. This actin
band is also associated with endocytosis [16], which removes the
yolk membrane as the advancing blastoderm/EVL cells move
vegetally over the yolk during epiboly and may be a driving force
in their vegetal movement. The most intense region of this F-actin
band associates with the leading edge of the EVL cells and is
implicated, together with the Misshapen kinase in regulating the
constriction of the marginal edge of EVL cells as they advance
vegetally [17].
Pharmacological inhibitors of actin or myosin can slow the later
stages of epiboly in zebrafish, implicating actin function in epiboly
progression [16]. Higher doses of these inhibitors can arrest
epiboly, but also cause either a dissociation of the EVL and
blastoderm cells or yolk herniation due to loss of the vegetal actin
mat that maintains the yolk integrity [16,42]. We tested several
actin or myosin inhibitors (cytochalasin B and D, Latrunculin A
and B, blebbistatin) for their ability to suppress the marginal
constriction in bbp mutants at 50% epiboly, however, none of them
can suppress the phenotype at doses that slow epiboly in WT
embryos (data not shown). Higher doses of some inhibitors can
arrest epiboly in WT embryos and block the very strong
constriction in bbp mutants; however, due to the many other roles
that actin plays in development, including cytokinesis, cell
adhesion, and general cell integrity, higher doses arrest develop-
ment in general and cause lethality (data not shown), precluding
our ability to block specifically the yolk cell constriction.
Loss of Mtx2, a predicted transcription factor, by morpholino
knockdown in zebrafish results in reduction of the YSL punctate
actin band and arrest in the vegetal movement of cells at the 50%
epiboly point [22,23]. Interestingly, mtx2 morphants also constrict
around the margin with a very similar phenotype to bbp mutants
[23]. However, the temporal progression of the constriction in
mtx2 morphants coincides with the normal timing of blastopore
closure in a WT embryo. That is, the margin constricts as if
epiboly were progressing normally, although the cells fail to move
vegetally. This contrasts the marginal constriction in bbp mutant
embryos, which occurs rapidly during a 20 to 30-minute window,
rather than over a 3-hour time period. The reduced punctate actin
band in mtx2 morphants may result in epiboly arrest. While the
remaining strong F-actin at the EVL margin may mediate the
marginal constriction observed in mtx2 morphants and may be
precociously activated in bbp mutant embryos.
In zebrafish, endogenous calcium release activity, as well as a
requirement for calcium during epiboly, supports the importance
of calcium signaling in epiboly progression [16]. Calcium levels are
H) Anti-myc antibody staining of WT (bbp/+) embryos expressing WT (F), bbp (G), and a non-phosphorylatable T202A/S252A/T315A triple mutation
(H) of myc-tagged MK2 (100 pg mRNA injected). I. Western blot of HeLa cell extracts expressing a vector control (lane 1), full-length myc-tagged MK2
(lane 2), truncated myc-tagged Bbp MK2 (lane 3), full-length kinase dead myc-tagged MK2 (lane 4), T202A/T315A myc-tagged MK2 (lane 5), T202A/
S252A/T315A myc-tagged MK2 (lane 6). (J) Western blotting of HeLa cell extracts expressing a vector control (lane 1), full-length untagged MK2 (lane
2), or truncated untagged Bbp MK2 (lane 3). (I, J) HeLa cell extract blots were probed for total MK2 protein (MK2) (top panels), total HSP27 protein
(middle panels), and phosphorylated HSP27 protein (bottom panels). (K) Western blot probed with anti-myc of embryo extracts either uninjected
(lane 1) or expressing myc-tagged MK2 constructs, as described in I.
doi:10.1371/journal.pgen.1000413.g006
Figure 7. Microinjection of DNp38a mRNA phenocopies bbp.
WT embryos microinjected with 250 pg of DsRed2 mRNA (A) or DNp38a
mRNA (B), which causes a bbp phenocopy.
doi:10.1371/journal.pgen.1000413.g007
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dynamic from 50 to 100% epiboly. Spikes of calcium are evident
in the yolk cell beginning at 50% epiboly, followed by waves of
calcium that traverse the blastoderm margin from 65% epiboly to
blastopore closure [16,24]. Loss of calcium causes a loss of the yolk
cell actin band and a blockage in epiboly progression [16].
Considering that calcium positively regulates actin contraction
[44], the dramatic increase in calcium release observed in bbp
mutant embryos (Fig. 4) is consistent with increased actin
contraction causing the abnormal morphogenesis movements.
During early epiboly when calcium release is normally infrequent,
we observed striking calcium dynamics in bbp mutants, coincident
with the abnormal shimmying movements observed prior to 50%
epiboly, suggesting abnormal F-actin contractile movements prior
to 50% epiboly. Furthermore, we observed increased and
sustained levels of calcium at the margin, when morphological
constriction is apparent. The constriction phenotype is remarkable
in its precise timing at specifically the 50% epiboly point in all
mutant embryos, coincident with the timing of robust F-actin band
formation at the YSL margin. We postulate that only when the F-
actin band fully forms at 50% epiboly in conjunction with EVL
marginal F-actin does the abnormal calcium regulation cause
lethality through an unregulated F-actin constrictive force.
One well characterized target of MAPKAPK2, HSP27, plays a
positive role in actin polymerization when phosphorylated by
MAPKAPK2 [45–49]. Our studies suggest that actin polymerizes
normally in bbp mutants, since the yolk cell actin band forms at
50% epiboly in bbp mutants. To our knowledge, there are no
known MAPKAPK2 targets that inhibit actin-myosin contraction
or calcium release. Thus, our results suggest a novel target of
MAPKAPK2 that normally restricts sustained actin constriction to
regulate tissue morphogenesis.
Although well studied in cell culture, MAPKAPK2 has been
little studied in model organisms. While a MAPKAPK2 gene exists
in both Drosophila and C. elegans, no mutant alleles have been
reported. RNAi screens in Drosophila cell culture suggest a role
for the fly homolog in cell cycle progression and cell shape
regulation [50,51].
In the mouse a targeted mutation of MAPKAPK2 is viable and
fertile, but exhibits defects in mediating inflammatory responses
[52–54]. Double mutants of MAPKAPK2 and the closely related
MAPKAPK3 in the mouse display more severe defects in the
inflammatory response, but do not exhibit developmental
abnormalities, although they are widely expressed in development
[55]. The third less related subfamily member, MAPKAPK5,
exhibits an incompletely penetrant embryonic lethal phenotype in
the mouse [56]. Generation of double and triple mutants of these
MAPKAPKs will be required to reveal potential overlapping
functions. Zebrafish have a duplicate MAPAPK2 gene that is not
expressed until 3 dpf (E. Brito and DSW, unpublished observa-
tion). Zygotic roles for MAPKAPK2 in zebrafish development
may be masked by the duplicate homolog or by the activity of
homologs of the other family members MAPKAPK3 and/or
MAPKAPK5, since MAPKAPK2/bbp homozygous zygotic mu-
tants in zebrafish are viable to adulthood, with no obvious
developmental defects.
The dramatic cell movements driving epiboly are crucial to the
development of the body plan of anamniote vertebrates. We show
that the p38 MAPK pathway is a critical component in regulating
this process within the teleost yolk cell. Future studies will be
required to reveal the mechanism by which this pathway regulates
blastopore closure in this fundamental cell movement process. The
early requirement for MAPKAPK2 and the accessibility of the
zebrafish embryo will provide an excellent in vivo model for
investigating the function and regulation of MAPKAPK2, which
has primarily been studied in cell culture. In particular
understanding the role of MAPKAPK2 during zebrafish epiboly
will be valuable in the identification of MAPKAPK2 inhibitors to
modulate the inflammatory response that MAPKAPK2 mediates
in chronic inflammatory conditions in humans.
Materials and Methods
Ethics Statement
The animal work in this study was approved by the Institutional
Review Board of the University of Pennsylvania School of
Medicine.
Phenotypic Characterization
All analyses were performed with the bbp
p58cd allele [18].
Optimized fixation protocols for the cytoskeletal proteins were
followed. Tubulin was visualized using KMX-1 (Boerhinger
Mannheim) and F-actin with rhodamine-phalloidin (Molecular
Probes) as described [57]. Myc-tagged protein was visualized by
fixing embryos in 4% PFA in PBS, blocking with 5% BSA and
0.5% Tween-20 in PBS and staining with anti-myc monoclonal
antibody 9E10 (University of Pennsylvania, Cell Center Service
Facility), followed by confocal microscopy. In situ hybridization
was performed using gsc and no tail [58], eve1 [59], bmp4 [60], and
foxb1.2 (formerly fkd3) [20].
Endocytosis was analyzed by incubating manually dechorio-
nated embryos in 1% rhodamine-dextran (MW 10,000, Molecular
Probes) in E3 medium from sphere stage to 50% epiboly as
described [8,61]. Fixed embryos were analyzed by confocal
microscopy.
For yolk cell membrane integrity studies, WT and bbp embryos
were incubated in hypertonic Ringers solution (116 mM NaCl,
2.9 mM KCl, 0.8 mM MgSO4, 1.8 mM CaCl2, 5 mM HEPES)
from the 4-cell stage through 24 hpf.
Blastoderm Transplants
Whole blastoderm transplants were performed as previously
described [27]. Briefly, mutant and WT embryos were injected at the
one-cell stage with 1 nl 2.5% rhodamine-dextran (MW 10,000,
Molecular probes) and 1 nl 0.05 mM Sytox Green (Molecular
Probes), respectively, in 0.1 M KCl. Embryos were dechorionated
and kept in E3 medium until the 1000-cell stage. Transplants were
performed in 16 Ringers solution (116 mM NaCl, 2.8 mM Kcl,
5 mM HEPES, 1 mM CaCl2, pH 7.2) containing 1.6% whipped
and cleared chicken egg whites. Blastoderms were separated from
yolks using a glass knife and hybrid embryos formed by placing
blastodermsonto naked yolks using slight pressure until adhered, then
transferred to 1/36Ringers solution after 15 minutes and analyzed.
Mapping, Molecular Identification and Cloning of bbp
Genomic DNA was pooled from mutant and WT sibling
females, and the bbp mutation, p58cd [18], mapped to a
chromosomal position using SSLP markers spaced throughout
the genome, as described [19,28]. SSLP markers flanking the
mutation (z22766 and z22355) were used to genotype individual
fish. Fish were generated for fine mapping by crossing bbp2/+
females to bbp2/2 males. Both bbp2/+ and bbp2/2 females
were scored for recombination between markers z22766 and
z22355.
cDNA was made from ovary RNA purified from bbp2/2 and
bbp+/+ fish using Superscript II (Invitrogen). MAPKAPK2 (MK2)
cDNA was amplified using the primers: 59-CCATC-
GATGGGTGTTGCCAAAGAAAGAC-39 and 59-GCTCTA-
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quenced and cloned into Cla1 and Xba1 sites in pCS2+. Full-
length WT and bbp MK2 were cloned into a pCS2+ vector
containing six tandem copies of a myc epitope (gift of Dr. Peter
Klein), yielding an N-terminal myc-fusion protein. Kinase-dead
myc-MK2 (K73M) was made by site-directed mutagenesis using
the primers: 59-GTGGGGAGAAGCTCGCTTTAATGATG-
CTTCATGACTGCCCAAA-39 and 59-TTTGGGCAGTCAT-
GAAGCATCATTAAAGCGAGCTTCTCCCCAC-39. Non-
phosphorylatable myc-MK2 (T202A, S252A, T315A) was made
by site-directed mutagenesis using the following primers in three
subsequent reactions: 59-ACACACAACTCTCTGGCCGCCC-
CCTGCTATACTCCTTATTAT-39 with 59-ATAATAAGGAG-
TATAGCAGGGGGCGGCCAGAGAGTTGTGTGT-39 (T202A),
59-GAATCATGGATTGGCAATTGCTCCTGGTATGAAGA-
AACGAAT-39 with 59-ATTCGTTTCTTCATACCAGGAG-
CAATTGCCAATCCATGATTC-39 (S252A), and 59-CAAT-
CAATGGAGGTTCCACAGGCACCCCTACACACCAGCCGT-
39 with 59-ACGGCTGGTGTGTAGGGGTGCCTGTGGAA-
CCTCCATTGATTG-39 (T315A). DNp38a (T181A, Y183F)
was generated from a WT p38a cDNA in pCS2+ (gift of T.
Hirano) by site directed mutagenesis with the primers 59-
GACACACAGATGATGAGATGGCCGGCTTTGTGGCCA-
CAAGGTGGTATC-39 59-GATACCACCTTGTGGCCACAA-
AGCCGGCCATCTCATCATCTGTGTGTC-39. Capped mRNA
was produced from pCS2+ constructs with mMessage mMachine
(Ambion) and injected into embryos, as previously described [62].
A MK2 morpholino, GTTGGCGTTAGTCAACATCTCCCAC
(Gene Tools, Philomath, Oregon) was injected at 5 ng/nl in 0.1 M
KCl at the one-cell stage.
For in situ hybridization of MK2, a probe was generated from
the pCS2+MK2 vector digested with HinDIII and transcribed
with T7 polymerase. SacII digestion, followed by SP6 polymerase
synthesis generated the sense control probe.
Cell Culture and Western Blotting
HeLa cells were grown in Dulbecco’s modified Eagle’s medium
(DMEM) supplemented with 10% fetal bovine serum (FBS),
penicillin and streptomycin, and GlutaMax (Gibco BRL) to a
density of 2610
5 per 35 mm plate at 37uCi n5 %C O 2. Cells were
transfected with tagged and untagged MK2 WT and mutant
plasmids,asdescribed[63].Cell lysates were analyzed bya standard
Western blot protocol using anti-MK2, anti-HSP27, anti-Phospho-
HSP27 (Assay Designs), and anti-Phospho-MK2 (Cell Signaling).
Zebrafish embryonic proteins were resolved as described [64] with
each lane containing 2 embryo equivalents. Western blotting was
performed with anti-myc monoclonal antibodies.
Imaging, Time-Lapse Microscopy and Confocal Analysis
Still images of live embryos and in situ hybridization were
captured with iVision (DVL Software). For time lapse-microscopy,
embryos were immobilized in individual chambers in 1% agarose in
E3 and covered by 3% methylcellulose in E3. Time-lapse movies
were created using OpenLab (Improvision, Beverly, MA). Confocal
analysis of tubulin and phalloidin staining, endocytosis, and
MAPKAPK2 localization was performed using a Zeiss confocal
and LSM510 software. For in vivo calcium imaging, 1-cell stage
embryos were microinjected with Fura-2 Dextran or Bis-Fura2
(Molecular Probes) and imaged as described [65]. Image pairs were
collectedat15-second intervalsthroughepibolystages.Forrescueof
the calcium defect, MAPKAPK2 RNA (90 ng/ul) co-mixed with
Texas Red (TxR) or TxR alone as a control was injected in the yolk
cell below the blastoderm at the 512-cell stage. Periodically frames
were collected at 560 nm to locate the TxR lineage marker and in
vivo calcium imaging performed as above. For YSN labeling,
embryos were injected in the YSL at 1000-cell stage with 1 nL of
0.25 mM Sytox Green in 0.1 M KCl. Embryos were mounted in
0.12% low melt agarose. Images were acquired on a Zeiss Axiovert
200 and processed in Axiovision software. For time-lapse movies,
images were processed in Photoshop, ImageJ and Quicktime Pro.
Supporting Information
Video S1 Microinjection of DNp38a mRNA phenocopies bbp.
WT embryos microinjected with 250 pg of DsRed2 mRNA (A) or
DNp38a mRNA (B), which causes a bbp phenocopy.
Found at: doi:10.1371/journal.pgen.1000413.s001 (7.30 MB
MOV)
Video S2 bbp YSN display normal movements until marginal
constriction. Animal view of WT (left panel) and age-matched
mutant (right panel). I-YSN rapidly contract to a small area of the
I-YSL.
Found at: doi:10.1371/journal.pgen.1000413.s002 (1.03 MB
MOV)
Video S3 bbp YSN display normal movements until marginal
constriction. Lateral view of WT (left panel) and age-matched
mutant (right panel). I-YSN rapidly contract to a small area of the
I-YSL.
Found at: doi:10.1371/journal.pgen.1000413.s003 (0.70 MB
MOV)
Video S4 WT embryos display controlled and consistent
calcium release during epiboly. Time-lapse movie of WT embryo
from early epiboly through 50% epiboly. Calcium release is
visualized by fura-2 and indicates the intensity of the release (stable
levels of calcium, cool colors indicating low intensity; dynamic
levels of calcium, warm colors indicating high intensity). WT
embryos maintain overall stable calcium release levels throughout
early epiboly.
Found at: doi:10.1371/journal.pgen.1000413.s004 (5.50 MB
MOV)
Video S5 bbp embryos display increasingly dynamic calcium
release prior to the bursting of the yolk. Time-lapse movie of bbp
embryo from early epiboly through bursting at 50% epiboly. Calcium
releaseis visualized by fura-2 and indicates the intensity of the release,
as in Movie 4. Ectopic calcium release increases dramatically over
timeasseen by sparksofhigh intensity. Frequencyand intensity ofthe
sparks increased simultaneously with the intensity of the shimmying
movements in the embryo and increased release at the cell margin,
culminating in the lethal bursting of the yolk.
Found at: doi:10.1371/journal.pgen.1000413.s005 (7.07 MB
MOV)
Video S6 DNp38a mRNA injection causes bbp phenocopy.
(Top 3 rows) 100 pg DNp38a mRNA injected embryos, (bottom
row) buffer control injected embryos. Nine of 12 DNp38 injected
embryos display yolk cell rupture phenotype. 5 minute intervals.
Found at: doi:10.1371/journal.pgen.1000413.s006 (9.31 MB
MOV)
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